Search
Hims&Hers: Novo Nordisk's Lawsuit is an 'Outright Attack'
2 day ago /
Read about 0 minute
Author：小编
On February 9, 2026, Hims&Hers stated that Novo Nordisk's lawsuit was an attack on the American public relying on generic drugs, accusing it of using the judicial system to limit consumer choices. Earlier that day, Novo Nordisk announced that it had filed a lawsuit alleging patent infringement by Hims&Hers over its generic semaglutide products sold in the U.S. market, aiming to prevent patients from accessing unregulated and safety-questionable counterfeit drugs, and to safeguard medication safety and intellectual property rights.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
